The success of the SmartDrive washing machine provided Fisher & Paykel with a platform for significant strategic transformation, leading to a period of diversification, global expansion, and structural change. The company's leadership recognized that sustained growth required not only continued innovation in existing product lines but also entry into new market segments and a more robust international presence. By the early 1990s, the traditional whitegoods market in developed economies was maturing, characterized by intense competition, price sensitivity, and increasing commoditization. This environment underscored the need for Fisher & Paykel to explore higher-margin businesses and leverage its distinctive engineering capabilities beyond domestic appliances, leading to several pivotal decisions that reshaped the company's identity and operational scope.
One of the most notable strategic shifts was the company's entry into the healthcare sector, specifically in respiratory care. This move, initiated in the early 1990s, was a significant departure from its core appliance business but leveraged the company’s strong engineering and manufacturing capabilities, particularly in precision motor control, humidification, and fluid dynamics. The initial exploration into healthcare was driven by an internal assessment of adjacent high-growth markets where Fisher & Paykel’s existing technological expertise could offer a competitive advantage. The development of humidification systems for respiratory therapy, particularly for continuous positive airway pressure (CPAP) therapy used in treating obstructive sleep apnea, as well as for critical care and neonatal respiratory support, opened up an entirely new revenue stream. This market, characterized by specialized products, stringent regulatory requirements from bodies like the FDA and CE, and a business-to-business (B2B) sales model primarily to hospitals and medical distributors, required significant investment in research and development, clinical trials, and a dedicated sales force. Fisher & Paykel Healthcare was thus established as a distinct, yet initially related, entity. This diversification into medical devices demonstrated a willingness to apply core competencies to high-growth, high-value markets beyond traditional consumer electronics, providing a hedge against the cyclical nature of appliance sales.
Concurrent with its venture into healthcare, Fisher & Paykel continued to innovate within its appliance division. The introduction of the DishDrawer dishwasher in 1997 represented another significant breakthrough. This product reimagined the conventional dishwasher by incorporating two independently operating drawers, offering unprecedented flexibility and efficiency for users. The design addressed common consumer pain points, such as the need to run partial loads without wasting water and energy, and improved ergonomics by reducing the need to bend down. Industry publications at the time lauded the design as a novel solution to consumer needs, with its innovative compact motor technology and precise water delivery systems contributing to its efficiency. The DishDrawer, like the SmartDrive, became a flagship product, reinforcing the company's reputation for design-led innovation and commanding a premium price point in the highly competitive kitchen appliance market against established multinational players such as Whirlpool, Electrolux, and Bosch.
To fund these ambitious growth initiatives and facilitate further international expansion, Fisher & Paykel undertook an initial public offering (IPO) on the New Zealand Exchange (NZX) in 2001. This transformative move transitioned the company from a privately held entity to a publicly traded corporation, providing access to capital markets for future investments in research, manufacturing, and global distribution networks. Critically, the IPO also allowed for a clearer financial and operational separation of the appliance and healthcare divisions, recognizing their distinct market dynamics, regulatory environments, and growth trajectories. As part of this process, Fisher & Paykel Appliances Holdings Ltd. and Fisher & Paykel Healthcare Corporation Ltd. were established as separate, independently listed companies in 2001. This dual listing enabled investors to allocate capital to either the mature, cash-generating appliance business or the high-growth, technology-intensive healthcare venture, thereby unlocking shareholder value and allowing each entity to pursue optimal strategic paths with dedicated leadership and resources.
However, this period of expansion and innovation was not without its challenges. The global appliance market, in particular, became increasingly competitive throughout the 2000s, with large multinational corporations leveraging their immense economies of scale, extensive global supply chains, and vast distribution networks. Fisher & Paykel faced significant pressures on pricing and market share, necessitating continuous investment in research and development to maintain its premium positioning and design differentiation. Competition from global giants like GE Appliances, Samsung, and LG Electronics intensified, particularly in emerging markets where volume was king. Furthermore, the global financial crisis (GFC) of 2008-2009 presented significant headwinds, impacting consumer spending, housing market activity, and discretionary appliance sales worldwide. The economic downturn led to temporary reductions in production volumes across Fisher & Paykel's manufacturing facilities, particularly in New Zealand, Italy, and Thailand, and necessitated workforce adjustments as the company sought to rationalize costs and manage inventory levels in response to reduced demand.
Internally, the challenge of managing two increasingly divergent businesses – high-volume consumer appliances with shorter product cycles and specialized, regulated medical devices with longer R&D pathways and different sales channels – became more pronounced even after their separate listings. While both leveraged engineering excellence, their market strategies, regulatory environments, customer bases (B2C vs. B2B/B2G), and required investment profiles were distinct. This practical and strategic divergence reinforced the earlier decision for a full, unencumbered separation. The 2001 dual listing effectively spun off Fisher & Paykel Healthcare as an independent company, allowing each to pursue its respective growth strategies with dedicated resources, focused leadership teams, and distinct corporate cultures. This separation allowed both companies to optimize their operations, attract specialized talent, and tailor their strategic focus, leading Fisher & Paykel Healthcare to become a global leader in respiratory humidification, while Fisher & Paykel Appliances continued its focus on premium home appliance innovation.
The final major transformation for Fisher & Paykel Appliances came in 2012 when it was acquired by Haier, a rapidly expanding Chinese multinational home appliance and consumer electronics company. According to press reports and company announcements at the time, Haier's acquisition, valued at approximately NZ$927 million, was a strategic move aimed at gaining a premium brand, advanced design capabilities, and access to established markets in Australia, New Zealand, and North America. For Fisher & Paykel Appliances, the acquisition provided access to Haier's vast manufacturing resources, significant economies of scale, and extensive global distribution channels, particularly in the rapidly growing Asian markets. This acquisition marked the end of Fisher & Paykel's independence as a New Zealand-owned and publicly traded appliance manufacturer, integrating it into a larger global corporate structure. Despite the change in ownership, the Fisher & Paykel brand retained its distinct identity and design philosophy, particularly its commitment to innovation and user-centric design, signifying a new chapter of global integration and continued product development under Haier's expansive umbrella.